Elsevier,
Alexis C.R. Hoste, Sigrid Görgen, Philippe Jacques, Chapter 10 - Increasing the natural biodiversity of microbial lipopeptides using a synthetic biology approach, Editor(s): Gloria Soberón-Chávez, In Foundations and Frontiers in Enzymology, Biosurfactants, Academic Press, 2023, Pages 203-247, ISBN 9780323916974
This content aligns with Goal 15: Life on land by investigating how synthetic biology can affect the synthesis of lipopeptides and increase their biodiversity.
Elsevier,
Overcoming Obstacles in Drug Discovery and Development
Surmounting the Insurmountable—Case Studies for Critical Thinking
2023, Pages 215-222
This content aligns with Goal 3: Good Health and Wellbeing by identifying the reactive metabolite responsible for the species-specific nephrotoxicity observed in rats dosed with efavirenz provide a framework for addressing nonclinical toxicities and clinical risk and providing a solid scientific basis for regulatory review.
Ticks: Biology, Ecology, and Diseases, 2023, Pages 193-215
This chapter advances the UN SDG Goal 3: Good Health by covering the range of approaches to the control of tick and tick-borne diseases.
Elsevier,
Manson's Tropical Diseases, Fourth Edition, Volume , 1 January 2023
This content aligns with Goal 3: Good Health by summarizing the current obstetric care in place, or lack thereof, in tropical regions. It recommends actions to create and improve quality, preventitive care where it is needed most and ultimately reduce maternal mortality rates in these regions.
Elsevier,
Clinical Immunology (Sixth Edition): Principles and Practice, 2023, Pages 972-982
This content supports the SDG Goal 3: Good health and well-being by exploring the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.
Elsevier,
Clinical Immunology (Sixth Edition): Principles and Practice, 2023, Pages 972-982
This content supports the SDG Goal 3: Good health and well-being by exploring the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.
